Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesSales of Property, Plant and EquipmentSales of Property, Plant and EquipmentShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Barinthus Biotherapeutics (BRNS) Cash from Operations (2020 - 2026)

Barinthus Biotherapeutics filings provide 7 years of Cash from Operations readings, the most recent being 3366000.0 for Q1 2026.

  • On a quarterly basis, Cash from Operations rose 77.41% to 3366000.0 in Q1 2026 year-over-year; TTM through Mar 2026 was 36443000.0, a 13.81% decrease, with the full-year FY2025 number at 47979000.0, down 65.79% from a year prior.
  • Cash from Operations hit 3366000.0 in Q1 2026 for Barinthus Biotherapeutics, up from 4242000.0 in the prior quarter.
  • In the past five years, Cash from Operations ranged from a high of 13086000.0 in Q4 2024 to a low of 19603000.0 in Q4 2023.
  • Median Cash from Operations over the past 5 years was 11191000.0 (2023), compared with a mean of 8567117.65.
  • Biggest five-year swings in Cash from Operations: surged 688.9% in 2022 and later crashed 272.46% in 2024.
  • Barinthus Biotherapeutics' Cash from Operations stood at 11343000.0 in 2022, then plummeted by 72.82% to 19603000.0 in 2023, then skyrocketed by 166.76% to 13086000.0 in 2024, then crashed by 132.42% to 4242000.0 in 2025, then rose by 20.65% to 3366000.0 in 2026.
  • The last three reported values for Cash from Operations were 3366000.0 (Q1 2026), 4242000.0 (Q4 2025), and 10726000.0 (Q3 2025) per Business Quant data.